COVID-19: Bahrain begins next phase of clinical trials for vaccine

Dubai: Bahrain has begun phase three of clinical trials for a COVID-19 vaccine, Bahrain News Agency (BNA) reported.

The clinical trials are being conducted in cooperation with those in charge of the experience from the UAE and their Chinese partners, Supreme Council of Health (SCH) President and National Medical Task Force to Combat the Coronavirus (COVID-19) Chairman, Lieutenant-General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, has revealed.

SCH chief was speaking as he received yesterday a delegation of the officials of the potential vaccine, including those in charge of the experience in the UAE, Dr. Nawal Al Kaabi and Dr. Waleed Abbas, in addition to representatives of Sinopharm’s China National Biotec Group (CNBG), and artificial intelligence and cloud computing company, Group 42.

Dr. Shaikh Mohammed bin Abdulla revealed that the kingdom will participate in the first global clinical trials for the third phase of WHO-listed potential coronavirus vaccine, noting that the vaccine will be tested on 6,000 volunteer citizens and residents in Bahrain.

SCH President highlighted the efforts made by the kingdom and the National Medical Task Force to Combat the Coronavirus to fight the pandemic and ensure the health and safety of the citizens and residents.